Repository of Research and Investigative Information
Shahid Sadoughi University of Medical Sciences
  |
 | Up a level |
(2022) Best insights on target molecules for drug design of nCOVID-19 based on pharmacological and peptide-based therapeutics. Health Biotechnology and Biopharma. pp. 62-81.
(2022) Evaluation of ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels in hospitalized COVID-19 patients with mucormycosis. Health Biotechnology and Biopharma. pp. 43-51.
(2022) Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma. Iranian Journal of Blood and Cancer. pp. 11-15.
(2022) Investigation of factors affecting adult erythrocyt sedimentation rate. Health Biotechnology and Biopharma. pp. 45-54.
(2022) Prevalence and impact of coagulation dysfunction in patients with COVID-19 in Yazd. Health Biotechnology and Biopharma. pp. 53-61.
(2022) Relationship between blood albumin level and clinical condition of patients with Covid-19 admitted to Shahid Sadoughi hospital in Yazd. Health Biotechnology and Biopharma. pp. 26-32.
(2021) Evaluating the level of knowledge of people referring to the comprehensive health services center about crimean congo hemorrhagic fever. Health Biotechnology and Biopharma. pp. 17-22. ISSN 25384414 (ISSN)
(2021) The Frequency of causes of vaginitis with Pap smear test in patients specially based on age as an effective agent on genetic factors. Health Biotechnology and Biopharma. pp. 15-23. ISSN 25384414 (ISSN)
(2021) The frequency of hepatitis C virus genotypes with chronic hepatitis C referred to Nikopour clinic in Yazd. Health Biotechnology and Biopharma. pp. 7-13. ISSN 25384414 (ISSN)
(2021) The frequency of intestinal parasites types in the samples studied in the hospital laboratory of Meybod. Health Biotechnology and Biopharma. pp. 51-57. ISSN 25384414 (ISSN)
(2021) The most common symptoms of COVID-19 patients in Yazd. Health Biotechnology and Biopharma. pp. 61-71. ISSN 25384414 (ISSN)
(2021) The rate of smoking and drug addiction among patients with COVID-19 specially based on sex genetic factor. Health Biotechnology and Biopharma. pp. 26-33. ISSN 25384414 (ISSN)